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1684-1182/Copyright ª 2015, TaiwanAbstract Background/purpose: As an immunofluorescence assay for enterovirus D68 (EV-
D68) is not available in the enteroviruses surveillance network in Taiwan, EV-D68 may be
the actual pathogen of untypeable enterovirus-suspected isolates.
Methods: The untypeable isolates collected from 2007 through 2014 were identified by nucleic
acid amplification-based methods and sequencing of the VP1 region to analyze the phylogeny
and epidemiology of EV-D68 in Taiwan.
Results: Twenty-nine EV-D68 isolates were sequenced, including 15 Cluster 3 and 14 Cluster 1
viruses. Approximately 41% of the patients were children under 5 years of age and their infec-
tions peaked in August. The ratio of male to female patients was 1.5 and 3.67 for Cluster 3 and
Cluster 1, respectively. Fever and respiratory symptoms were commonly reported in EV-D68-
infected patients. The results of phylogenetic analyses showed that EV-D68 isolates between
2007 and 2014 belonged to different clusters and existed for years, indicating that endemic cir-
culation of EV-D68 existed in Taiwan.
Conclusion: This study showed that EV-D68 has been endemic in Taiwan for some years despite
a small number of positive cases. The continuous monitoring and efforts towards the improve-
ment of diagnostic techniques are required to complete the surveillance system. This study
provided the genetic and epidemiological information which could contribute to understanding
the etiology and epidemiology of EV-D68.
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+ MODELIntroductionEnterovirus D68 (EV-D68) contains a positive-sense, single-
stranded RNA genome, and belongs to the family of Picor-
naviridae, the genus of Enterovirus, and the species of
Enterovirus D. There are five known serotypes in the spe-
cies of Enterovirus D, namely EV-D68, EV-D70, EV-D94, EV-
D111, and EV-D120.1 EV-D68 was first isolated from samples
obtained in California in 1962.2 Unlike other enteroviruses,
EV-D68 is associated with respiratory illness, and shares
important biological and molecular properties with both
the enteroviruses and the rhinoviruses.3 However, the full
spectrum of clinical diseases caused by EV-D68 is still
unclear.
EV-D68 infections have been reported in Japan
(2005e2010), China (2006e2012), Thailand (2006e2011),
Italy (2008e2009), the United Kingdom (2008e2010), Kenya
(2008e2011), France (2009), Philippines (2009e2011), the
United States of America (USA; 2009e2010), New Zealand
(2010), and The Netherlands (2010).4e14 The majority of
previously reported EV-D68 cases were associated with acute
respiratory infections, and were implicated in some rare
cases of fatal infections.15 In the USA, between 1997 and
2005, the most common age group associated with EV-D68
was children aged between 1 year and 4 years, but approxi-
mately one fourth of all infections were reported in adults.16
EV-D68 was reported rarely in the USA in the past, and
only small clusters of EV-D68 associated with respiratory
illness were reported between 2009 and 2010.4 Abnormally,
an increase in EV-D68-confirmed patients with severe res-
piratory illness was noted after August 2014.17 As of
January 15, 2015, a total of 1153 laboratory-confirmed
cases were identified.18
For disease surveillance, the Taiwan Virology Reference
Laboratory Network, covering all four regions in Taiwan,
has been set up by Taiwan Centers for Disease Control
(Taiwan CDC) since 1999 in cooperation with virological
laboratories and physicians.19 The virus isolation combined
with immunofluorescence assay (IFA) and molecular
methods were used for the detection of pathogens in this
network. However, EV-D68 could not be confirmed by using
commercial IFA kits, and some isolates were reported as
untypeable enteroviruses that may be identifiable as EV-
D68. Only molecular methods and sequence analysis could
be used for the confirmation and molecular typing for EV-
D68. In a previous study, some enteroviruses of the spe-
cies enterovirus D were detected in Taiwan from 2007
through 2012.20 However, no genetic or epidemiological
analyses were available. In this study, the untypeable iso-
lates were reexamined by reverse transcription polymerase
chain reaction (RT-PCR)-based methods and sequence
analysis to survey the epidemiology of EV-D68 in Taiwan.
Methods
Ethical statement
The project was reviewed and approved by the Institutional
Review Board (IRB) of the Taiwan CDC (IRB No. 101011,
102017, and 103305). Based on Taiwan’s Communicable
Disease Control Act, informed consent is not necessary forPlease cite this article in press as: Huang Y-P, et al., Molecular and
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.collecting clinical specimens from patients with suspected
notifiable communicable diseases. If these samples were
used for research purposes, they must be de-identified
prior to publication. In this study, all EV-D68 strains isolated
from patients were de-identified according to the IRB
approved protocol of Taiwan CDC to meet the patient
confidentiality guidelines.
Specimen collection and selection criteria of EV-
D68 for analysis
Throat swabs, rectal swabs, stools, sera, or cerebrospinal
fluid specimens from patients with suspected enterovirus
infections were collected, and the viruses were isolated
following the standard protocols for the enterovirus sur-
veillance system conducted by Taiwan CDC as previously
described.21 The virus isolates were then identified by IFA
using commercial antibodies against enterovirus (Light Di-
agnostics, Millipore Corporation, Billerica, MA, USA) ac-
cording to the manufacturer’s protocol. IFA-untypeable
isolates were then sent to Taiwan CDC for EV-D68 identifi-
cation.22 The selection of EV-D68 viruses for analysis in the
study was based on the following criteria: (1) strains iso-
lated in each year were included; (2) for the yearly number
less than five, two isolates were randomly selected for each
year; (3) if there was more than six isolates, approximately
one third of them were randomly selected; and (4) all iso-
lates collected in 2014 were used to compare with those in
the 2014 outbreak in the USA.
RNA extraction and RT-PCR amplification
QIAamp Viral RNA Mini Kit (Qiagen, Santa Clara, CA, USA)
was used for RNA extraction according to the manufac-
turer’s instructions. At first, all the IFA-untypeable entero-
viruses were tested by traditional RT-PCR and sequencing.22
Then, an enterovirus COnsensus-DEgenerate Hybrid Oligo-
nucleotide Primers (CODEHOP) method was used to identify
untypeable enteroviruses.23 The VP1 region was amplified
by RT-PCR with primer sets 484/222 and 292/485 as previ-
ously described.3 The Basic Local Alignment Search Tool
(BLAST) was used for virus classification and genotyping
using the reference sequence database in GenBank.
Phylogenetic analysis
The nucleotide and deduced amino acid sequences of the
VP1 region were aligned using BioEdit program, and the
phylogenetic tree was constructed by MEGA program
(version 5, http://www.megasoftware.net) using the
neighbor-joining method with a bootstrap value of 1000.24
An amino acid substitution map was performed based on
the entropy values of VP1 sequences. Different amino acid
residues were indicated by different colors with single-
letter abbreviations. Meanwhile, only the amino acids
with entropy values over 0.5 were shown.
Clinical data
Clinical data were obtained from medical records in the
surveillance system, including the records of patients’ age,epidemiological study of enterovirus D68 in Taiwan, Journal of
1016/j.jmii.2015.07.015
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scored as the following characteristics: fever, respiratory
tract symptoms (cough, rhinorrhea, sore throat, or respi-
ratory infections), and gastrointestinal tract symptoms
(diarrhea, vomiting, or abdominal distention). Clinical
symptoms were compared using Fisher’s exact test. A p
value < 0.05 was considered statistically significant.
Nucleotide sequence accession numbers
Twenty-nine EV-D68 sequences generated in this study have
been deposited into GeneBank. The accession numbers of
these isolates are KP657701eKP657729.
Results
EV-D68 identification
Between 2007 and 2014, a total of 575 untypeable
enteroviruses-suspected isolates were tested by CODEHOP-
based PCR, in which 65 EV-D68 strains were confirmed by
sequencing. The yearly numbers of EV-D68 isolates from
2007 to 2014 were 15, three, four, 18, 11, two, four, and
eight, respectively. Based on the selection criteria, 29
strains were selected for phylogenetic analysis in the study,
including 21 strains isolated from 2007 to 2013 (4, 2, 2, 6, 3,
2, and 2, respectively) and eight strains from 2014.20 The
yearly distribution of different clusters of enterovirus D68
between 2007 and 2014 in Taiwan is shown in Figure 1.
Phylogenetic analysis of EV-D68
The major phylogenetic clusters (1, 2, and 3) of EV-D68
have been described previously.25,26 As shown in Figure 2,
29 partial VP1 genomic region sequences of enterovirus D68
isolated in Taiwan between 2007 and 2014 were used for
phylogenetic analysis, in which 15 isolates were identified
as Cluster 3, and 14 isolates as Cluster 1 viruses. The Cluster
3 viruses with sequence similarity ranged from 85% to 88%
when compared to the prototype strain Fermon. However,Figure 1. Yearly distribution of different clusters of
enterovirus D68 between 2007 and 2014 in Taiwan. Based on
molecular detection methods and the Basic Local Alignment
Search Tool (BLAST), genotyping results of the 29 enterovirus
D68 isolates collected from 2007 through 2014 in Taiwan are
shown. Cluster 1 is indicated in blue, while Cluster 3 is indi-
cated in red.
Please cite this article in press as: Huang Y-P, et al., Molecular and
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.they clustered closely with recently genotyped EV-D68 se-
quences including the strains in the USA, China, Japan, The
Netherlands, Spain, and Gambia. Among them, the Cluster
3 viruses in Taiwan were grouped into two major lineages.
Similar to Cluster 3 viruses, the Cluster 1 isolates in Taiwan
(n Z 14), including all eight isolates in 2014, were 86e88%
homologous to the prototype strain Fermon. Among them,
the isolates in 2014 were closely related to the Taiwan
isolates in 2011e2012 (Figure 2). Interestingly, some unique
amino acid substitutions (residue 90 N/D, residue 243
I/V) were observed in Cluster 1 (Figure 3). The American
isolates in 2014 were also grouped in Cluster 1 and Cluster
3. However, these American isolates were genetically
different from the Taiwan isolates in 2014 according to the
phylogenetic analysis.
Epidemiology and clinical data
Cluster 3 viruses were detected in 2007, 2009, 2010, 2011,
and 2013, while Cluster 1 viruses were detected in 2007,
2008, 2011, 2012, and 2014. Both Cluster 3 and Cluster 1
viruses were found in 2007 and 2011, but no Cluster 2 vi-
ruses were found (Figure 1).
The ratio of male to female patients infected with
Cluster 3 and Cluster 1 was 1.5 and 3.67, respectively
(Table 1). In addition, Cluster 3 viruses were nearly seen
throughout the year, while Cluster 1 viruses were more
likely to be detected in the typical enterovirus season
(Figure 4).
Clinical symptoms of EV-D68 infected patients are sum-
marized in Table 1. No fatalities were reported. In general,
only mild symptoms were observed. Fever was the most
frequent clinical symptom in both Cluster 3 and Cluster 1
EV-D68-detected patients, followed by respiratory symp-
toms (cough, rhinorrhea, and sore throat). No significant
differences of respiratory tract or gastrointestinal tract
symptoms were shown between Cluster 3-infected patients
and Cluster 1-infected patients (p > 0.05), but Cluster 1 EV-
D68-infected patients had significantly more fever when
compared to Cluster 3-infected patients (p < 0.05; Table
1).
Discussion
EV-D68 deserves more attention in recent years, especially
in 2014 due to the nationwide outbreak associated with
severe respiratory illness in the USA. About 2600 specimens
were tested by the US-CDC during 2014, andw36% of those
tested positive for EV-D68. Almost all the confirmed cases
of EV-D68 infection were children. Fourteen people infec-
ted with EV-D68 have died, but it is still unknown what role
the virus played in their deaths.18 Furthermore, the viruses
identified in 2014 were genetically related to strains of EV-
D68 that were detected in previous years in the USA,
Europe, and Asia.
To the best of our knowledge, this is the first reported
characterization of EV-D68 clinical isolates in Taiwan. This
study has confirmed that a number of untypeable entero-
viruses collected during enterovirus surveillance by Taiwan
Virology Reference Laboratory Network from 2007 to 2014
were EV-D68 cases. These cases were tested by sensitiveepidemiological study of enterovirus D68 in Taiwan, Journal of
1016/j.jmii.2015.07.015
Figure 2. Phylogenetic analysis of partial VP1 gene sequence (nucleotides 132e471) of enterovirus D68 isolated from 2007 to
2014 in Taiwan. The Taiwan EV-D68 isolates in 2014 are indicated by triangles, while the American EV-D68 isolates in 2014 are
indicated by circles.
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phylogenetic analysis. About 52% of the EV-D68 cases
belonged to Cluster 3, and the others belonged to Cluster 1.
Of them, two cases in Taiwan in 2014 are grouped in Cluster
1 and showed 94e96% similarity of VP1 region with the
Cluster 1 viruses isolated in the USA in 2014. The presence
of these EV-D68-positive isolates revealed the diagnostic
deficit in enterovirus surveillance, since there were no
standard EV-D68-specific diagnostic methods. In addition,
the true number and incidence rate of EV-D68 is probably
underestimated because cases with mild symptoms may not
be reported, or might be misidentified as rhinovirus.4 A
standard diagnostic technique for EV-D68 is needed. In this
study, EV-D68 isolates were identified and confirmed fromPlease cite this article in press as: Huang Y-P, et al., Molecular and
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.the untypeable enteroviruses by nucleic acid amplification
methods and sequence analysis.
Both Cluster 1 and Cluster 3 viruses of EV-D68 were
detected in this study and peaked in August, but no
apparent correlation with seasonal distribution was
observed in Taiwan. A further investigation is needed since
the number of cases in each cluster is low. However, Ikeda
et al14 reported that EV-D68 infections have a clear sea-
sonality, as described in another surveillance report in The
Netherlands.25 In addition, most EV-D68 infections were
detected during the rainy season in Thailand,6 while the
peak of EV-D68 detection in China was from August to
October.8 By contrast, w41% of the EV-D68-infected pa-
tients in this study were aged  5 years, which was in lineepidemiological study of enterovirus D68 in Taiwan, Journal of
1016/j.jmii.2015.07.015
Figure 3. Phylogenetic analysis and amino acid substitutions of enterovirus D68 in Taiwan based on the VP1 gene sequence.
Amino acid substitutions were labeled by different colors through a proteotyping map. Only entropy values > 0.5 were shown, and
amino acid position were indicated in each column. The Taiwan EV-D68 isolates in 2014 are indicated by triangles, while the
American EV-D68 isolates in 2014 are indicated by circles.
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5 years and the adults are also targeted by EV-D68.4,6
Previous studies demonstrated that EV-D68 was associ-
ated with respiratory diseases,14 and the phenomenon was
also found in this study. Fever and respiratory illness were
the most common symptoms among these EV-D68-infected
patients in Taiwan. The Taiwan EV-D68 viruses showed
high similarity (94e96%) in VP1 region with the viruses in
the USA in 2014. The description of the nationwidePlease cite this article in press as: Huang Y-P, et al., Molecular and
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.outbreak of EV-D68 in the USA specifically focused on more
severe or hospitalized cases, but there were most likely
more milder cases in the USA than reported. By contrast,
only mild EV-D68-associated symptoms were observed in
Taiwan. However, in this study, the clinical information
collected by the physicians and reference laboratories at
the very beginning was limited, and no more details were
available in such a retrospective study. More samples,
complete case histories, and studies are needed to clarifyepidemiological study of enterovirus D68 in Taiwan, Journal of
1016/j.jmii.2015.07.015
Table 1 Characteristics and clinical symptoms of cases
infected with different clusters of enterovirus D68 from
2007 to 2014.
Characteristics and
clinical symptoms
Patients, n (%) p
Cluster 3 Cluster 1
Sex 0.4270
Female 6 (40) 3 (21)
Male 9 (60) 11 (79)
Age (y) 0.0837
5 5 (33) 7 (50)
6e17 2 (13) 5 (36)
18 8 (53) 2 (14)
Fever 7 (47) 13 (93) 0.0142*
Respiratory tract
symptoms
11 (73) 9 (64) 0.6999
Gastrointestinal
tract symptoms
1 (7) 1 (7) > 0.99
Total 15 14
* Statistically significant.
Figure 4. Seasonal distribution of enterovirus D68 in Taiwan.
Seasonal distribution of different clusters of the 29 enterovirus
D68 isolates collected from 2007 to 2014 in Taiwan are shown.
Cluster 1 is indicated in blue, while Cluster 3 is indicated in
red.
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presentation, and seasonal distribution as well.
A large increase in respiratory illness associated with EV-
D68 has been reported in Africa, Asia, Europe and North
America in recent years.6,7,12,17,27 Genetic differences of
several clusters were identified among these circulating
strains. The EV-D68 isolates in Taiwan from 2007 to 2014
belonged to Cluster 1 and Cluster 3, indicating the exis-
tence of endemic circulation of EV-D68 in Taiwan. Based on
the phylogenetic analysis using VP1 sequences, the EV-D68
viruses could be divided into three main clusters, despite
different grouping names.5,6,14,25,27,28 Some amino acid
substitutions, especially in the BC and DE loop, were found
in specific clusters, which may change the antigenicities. It
is suggested that the emergence of strains with different
antigenicities was the possible reason for the increased
detection of EV-D68 in recent years.29 In addition, one
specific amino acid exchange in the BC loop of VP1 region of
coxsackievirus B4 could lead to the loss of reactivity with
specific antibodies.30 The EV-D68 isolates in Taiwan in 2014Please cite this article in press as: Huang Y-P, et al., Molecular and
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.were grouped in the same cluster and were genetically
similar to each other. These Taiwan EV-D68 viruses were
isolated from the patients since July, and did not cause
severe illness, unlike the ones identified in the USA in 2014.
Nonetheless, it is still unclear why the EV-D68 viruses
caused different degree of illness in spite of the high sim-
ilarity between the viruses in Taiwan and the USA.
In conclusion, firstly, this is the first report of EV-D68
infections in Taiwan, and the results showed that EV-D68
has been circulating for years in this country. Secondly,
continuous monitoring and efforts towards the improve-
ment of diagnostic techniques are required to complete the
surveillance system. Thirdly, our study provided the genetic
and epidemiological information which could contribute to
understanding the etiology and epidemiology of EV-D68.
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